{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:07:03Z","timestamp":1786446423923,"version":"build-2736575974"},"reference-count":10,"publisher":"American Association for Cancer Research (AACR)","issue":"1","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,12]]},"abstract":"<jats:title>Summary:<\/jats:title>\n                  <jats:p>In this issue of Blood Cancer Discovery, Pomeroy and colleagues explore a population pharmacokinetic\/pharmacodynamic model of axicabtagene ciloleucel in large B-cell lymphoma, quantifying how tumor debulking before chimeric antigen receptor (CAR) T-cell infusion can significantly improve durable remission rates. Their framework incorporates mechanistic modeling principles of CAR T-cell biology and therapy, such as CAR T-cell expansion, binding, killing, and stochastic CD19 loss, providing actionable insights for optimizing combination approaches and future trial design.<\/jats:p>\n                  <jats:p>See related article by Pomeroy et al., p. 41<\/jats:p>","DOI":"10.1158\/2643-3230.bcd-25-0397","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T14:37:03Z","timestamp":1763649423000},"page":"11-14","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond Expansion: Tumor Debulking as Key to Improving CAR T-Cell Potential in Lymphoma"],"prefix":"10.1158","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7731-3345","authenticated-orcid":false,"given":"Philipp M.","family":"Altrock","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Clinical Research Unit CATCH-ALL, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"2026011203064332800_bib1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"N Engl J Med"},{"key":"2026011203064332800_bib2","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1182\/bloodadvances.2020002394","article-title":"Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma","volume":"4","author":"Locke","year":"2020","journal-title":"Blood Adv"},{"issue":"Suppl 1","key":"2026011203064332800_bib3","first-page":"S147","article-title":"Chimeric antigen receptor T cell therapies: a review of cellular kinetic-pharmacodynamic modeling approaches","volume":"60","author":"Chaudhury","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"2026011203064332800_bib4","first-page":"41","article-title":"A pharmacologic model predicts that tumor debulking and improves CAR T-cell efficacy in large B-cell lymphoma","volume":"7","author":"Pomeroy","year":"2026","journal-title":"Blood Cancer Discov"},{"key":"2026011203064332800_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/psp4.12388","article-title":"Tisagenlecleucel model-based cellular kinetic analysis of chimeric antigen receptor-T cells","volume":"8","author":"Stein","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"2026011203064332800_bib6","article-title":"Modelling cell population dynamics during chimeric antigen receptor T-cell therapy","volume-title":"Cancer Systems Biology, Translational Mathematical Oncology","author":"Altrock","year":"2025"},{"key":"2026011203064332800_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11538-024-01400-2","article-title":"Integration of immune cell-target cell conjugate dynamics changes the time scale of immune control of cancer","volume":"87","author":"Yang","year":"2025","journal-title":"Bull Math Biol"},{"key":"2026011203064332800_bib8","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41375-025-02582-x","article-title":"Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy","volume":"39","author":"Iacoboni","year":"2025","journal-title":"Leukemia"},{"key":"2026011203064332800_bib9","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1158\/1538-7445.AM2025-3199","article-title":"Abstract 3199: radiomic features associated with anti-tumor activity in Non-Hodgkin lymphoma patients treated with CD19 directed allogenic CAR T therapy","volume":"85","author":"Dunn","year":"2025","journal-title":"Cancer Res"},{"key":"2026011203064332800_bib10","first-page":"cpt.70077","article-title":"Foundational principles for the quantitative translation of T-cell therapeutics for hematologic malignancies and immunology","author":"Ashcroft","year":"2025","journal-title":"Clin Pharmacol Ther"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-25-0397\/3672713\/bcd-25-0397.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/7\/1\/11\/3723318\/bcd-25-0397.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/7\/1\/11\/3723318\/bcd-25-0397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:06:49Z","timestamp":1768205209000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/7\/1\/11\/771351\/Beyond-Expansion-Tumor-Debulking-as-Key-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,11,20]]},"published-print":{"date-parts":[[2026,1,12]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-25-0397","relation":{},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}